Visit our website: www.uhb.nhs.uk
For patients, staff, visitors and volunteers
MARCH 2018
Page 7 Fundraising inspiration
Page 5 Take the challenge to become healthier
Page 13 Taking time to support colleagues Be on alert to beat norovirus risks
Teams from across the Trust came together to look at ways to help patients leave hospital. For the full story see centre pages
Life-saving trial to probe liver disease Consultant liver physician Dr Dhiraj Tripathi has been awarded a £2.3 million research grant to lead a ground-breaking clinical trial as Chief Investigator which aims to save lives and essential NHS funds. Currently, liver Dr Dhiraj Tripathi disease is the fifth biggest killer in the UK and deaths are amongst relatively young patients. A complication of diseases of the liver is internal bleeding, which if unstoppable, can be lethal or lead to prolonged intensive care treatment. Dr Tripathi, who is also an Honorary Reader at the University of Birmingham, welcomed the funding from the National Institute of Health Research, NIHR. He said: “CALIBRE (Carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis) has the potential to be the largest ever clinical trial of its kind in the history of hepatology in the UK.”
The trial is to be rolled out nationally and all hospitals with gastroenterology and hepatology services, as well as research facilities, are eligible. The results could lead to a major shift in the management of patients with liver cirrhosis and varices, with significant implications for the NHS.”
The results could lead to a major shift in the management of patients with liver cirrhosis and varices, with significant implications for the NHS Dr Dhiraj Tripathi Liver Consultant The clinical trial will be co-ordinated through the Birmingham Clinical Trials Unit (BCTU) based at the University of Birmingham, under the leadership of its director Professor Peter Brocklehurst who said: “This is a large trial which needs to recruit over 2,600
patients, which will make it the largest trial carried out in the UK involving patients with liver disease. There is fantastic support for this trial from liver specialists throughout the UK and we are very optimistic that it will help us to find an answer to this really important research question in about six years’ time.” The trial will compare two different approaches to preventing potentially deadly bleeding from enlarged internal blood vessels (varices) in patients with liver cirrhosis. Both treatments are currently offered to patients, but a large high-quality trial to assess which has the best result has not been tried before. Dr Tripathi also acknowledged important contributions from expert co-applicants in the hepatological field at the University Hospitals Birmingham (Dr James Ferguson), University of Edinburgh (Professor Peter Hayes), University of Leeds (Dr Ian Rowe) and the Royal Liverpool Hospital (Dr Paul Richardson). There has also been considerable patient and public involvement and support from the British Society of Gastroenterology (BSG) and British Association for the study of the Liver (BASL).
A number of wards were affected by norovirus in February therefore all staff are asked to remain vigilant for further signs of infection in their patients. Norovirus spreads rapidly and causes a sudden onset of diarrhoea and vomiting. The Trust has identified that outbreaks started after an infected relative visited a ward and passed on the virus, and where a patient with norovirus symptoms had been transferred to a bay with other patients. There are three key actions for senior staff: ` Ensure all visitors to your ward do not have symptoms of diarrhoea, vomiting or flu-like illness, please ask them to visit only after 48 hours have passed since their symptoms have ended ` Ensure patients with diarrhoea, vomiting and flu-like illness are isolated in a side room ` Report concerns to the Infection Prevention and Control Team immediately on Ext: 13785 To limit the spread of infection, we ask that all staff remain extremely vigilant and identify patients with any symptoms as quickly as possible, ensuring that the patient is isolated in a single room and that stool and/or vomit samples are sent to microbiology. Staff must also maintain strict hand hygiene and the correct use of personal protective equipment. If you have a patient with diarrhoea and/ or vomiting, please ensure you are following Trust procedure, available here: ¬ http://uhbpolicies/assets/ DiarrhoeaOutbreakProcedure.pdf For further information or advice, please contact the Infection Prevention and Control Team on: Ext: 13785. Out of hours, please call the on-call microbiologist via switchboard. ƀ infectioncontrolnurseteam@uhb. nhs.uk All visitors are reminded that they should wash their hands with soap and water, drying them thoroughly on entering AND leaving any ward or clinical area to help limit the spread of bacteria. If you have had diarrhoea or vomiting you must not visit the hospital until 48 hours after your last sickness or diarrhoea episode.
Delivering the Brainteasers, best in care mind benders and more p15 • Find your way around: Hospital maps p16 Puzzle page: